Key facts
- This page summarizes Mark Goodman's Form 4 filing for Orgenesis Inc. (ORGS).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 19 Jul 2024, 11:26.
Mark Goodman - 27 Jun 2024 Form 4 Insider Report for Orgenesis Inc. (ORGS)
- Reporting relationship
- Director
- Issuer ticker
- ORGS
- Reported as of
- 27 Jun 2024
- Net transaction value
- $0
- Reporting owner signature
- /s/ Mark Goodman
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Mark Goodman filed Form 4 for Orgenesis Inc. (ORGS) on 19 Jul 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ORGS
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +6,250
- Change %
- Price
- $0.000000
- Shares after
- 6,250
- Date
- 27 Jun 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,250
- Exercise price
- $0.6300
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Equal vesting over the next 3 years, subject to the reporting person's continued service through the applicable vesting dates.